Amazon Eczema Cream Recall Over Staph Infection Risk
Amazon Eczema Cream Recall Over Staph Infection Risk

An eczema cream sold on Amazon has been recalled due to potential contamination with Staphylococcus aureus bacteria, which can cause serious infections. The U.S. Food and Drug Administration (FDA) announced the recall on Friday, warning that the product could lead to life-threatening conditions.

The affected cream is Pharmacal's MG217 Multi-symptom Treatment Cream & Skin Protectant Eczema Cream, sold in six-ounce tubes. The specific lot number is 1024088, with expiration date November 2026. The product code is 5106, and the UPC is 012277051067.

The FDA stated that individuals with weakened immune systems or compromised skin are at higher risk of severe infections, including sepsis and septic shock. Although no adverse events have been reported, Pharmacal has notified distributors and urged consumers to stop using the cream and seek a refund from the point of purchase.

Wide Pickt banner — collaborative shopping lists app for Telegram, phone mockup with grocery list

Staphylococcus aureus can cause skin issues such as boils and blisters, typically treated with antibiotics or topical creams. This recall follows other recent U.S. product recalls due to contamination, including eye drops and stain removers.

Pickt after-article banner — collaborative shopping lists app with family illustration